Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.
Also called NCT03980990
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT03980990
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Unknown status
Technical summary
Registry record NCT03980990. Randomized; no masking; primary purpose treatment. Start 2019-06-17 (actual); primary completion 2020-06-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
- Condition
- Acute Coronary Syndrome
- Condition
- Unstable Angina
- Condition
- Diabetes Mellitus
- Condition
- Metformin Adverse Reaction
- Intervention (Drug)
- Metformin
- Lead sponsor
- University of Saskatchewan
Record details
- Record id
cardio:ct-nct03980990- Content hash
0d407bde1ae0582b07226e1b9758b9242392b698d324c4c304575cee7a881adc